Pharma supply chains under strain as memory, batteries and launch capacity tighten

Pharmacy shelves in England are emptier than the headlines suggest. Community Pharmacy England said on 30 September that autumn brings renewed pressures on medicines supply. Practice Business reported on 1 October that common medicine shortages are affecting NHS trusts. The two items landed within 24 hours of each other and describe the same problem from opposite ends of the chain.

The pattern is not confined to the UK. Swiss outlet lenews.ch reported on 25 September that more than 700 medicines face shortages in Switzerland. The Guardian reported on 29 September that hospitals in England are hit by shortages of common drugs such as paracetamol.

A memory shortage that reaches into the clinic

The newest and most concrete development in the dossier came from the semiconductor side. On 1 October, Micron told its FY 2026 earnings call that RAM and storage chip shortages will worsen in 2027 and 2028. It also announced a record gross margin of 86.25%, according to Tom's Hardware. CEO and chairperson Sanjay Mehrotra said the company has already sold most of its capacity for next year. Customers will pay more than in 2026.

"In calendar 2027 as well as 2028, we see demand exceeding supply. In fact, we see greater tightness in the industry in 2027 and in 2028 versus 2026. Overall, supply-demand environment is only getting tighter," Mehrotra said. "We do not have line of sight to when supply and demand will return to balance."

That matters for pharmacy because hospital systems, cold-chain monitoring, dispensing robots, electronic patient records and the scanners that track pallets of medicines all run on memory and storage. Micron forecast $61.5 billion in FQ1 revenue. It expects NAND and DRAM shipments to grow in the low-to-mid 20s percentage range for the next two years, but still expects the industry to remain supply constrained in both years. New fabs are coming online, the company said, but they take years to produce chips.

The same week brought a smaller but sharper warning about how software, not silicon, is now part of the supply chain. The Hacker News reported on 1 October that vulnerability exploitation has overtaken phishing as the leading initial access vector for breaches in financial services. More than half of financial services vendors carry at least one high-severity CVE. An exception signed off months ago, it notes, rests on an outdated threat model.

Europe's industrial gaps, from Budapest to Valencia

At the Pretzl Connect 2026 press event in Budapest, Kate Underhill, future space transportation propulsion architect at the European Space Agency, told EE Times that Europe's reliance on foreign semiconductors affects industrial strategy well beyond space. According to EE Times on 1 October, Underhill said space systems typically operate "at least 10 years behind consumer electronics." She gave an example in which ESA tried to order just 20 laser diodes from a German company but the supplier required a minimum order of 10,000 units.

Underhill also said European satellite developers often face compliance challenges tied to U.S. International Traffic in Arms Regulations. "If there is any U.S. component on your satellite, then you have to comply with U.S. regulations," she said. The logic applies to any sector buying specialised components at small volumes, including medical devices and radiopharmaceutical equipment.

Battery and materials supply chains are being redrawn in parallel. CnEVPost reported on 28 September that Gotion High-tech and Volkswagen's PowerCo plan to jointly invest about €3.22 billion ($3.67 billion) in battery and materials projects in Spain, Slovakia and Morocco, through three joint ventures. Gotion will invest about €1.6 billion and PowerCo about €1.62 billion, with funding provided in stages.

The largest project, in Valencia, Spain, calls for about €2.26 billion for 29.1 GWh of annual lithium-ion capacity. Šurany, Slovakia, is set for about €480 million for 8.4 GWh. Kenitra, Morocco, will see about €480 million for 100,000 metric tons of lithium iron phosphate cathode materials. The filing says the board approved the proposal on 28 September but the companies have yet to sign the investment agreement. The deal still requires shareholder approval and government clearances in China and overseas. Gotion said financing, approvals and market changes could affect construction progress and expected returns. Gotion's global EV battery installations totalled 34.0 GWh in the first seven months of 2026, up 44.2% year on year, according to SNE Research.

Construction and logistics capacity is being automated at the same time. The Robot Report reported on 30 September that Autonomous Solutions Inc. and SoftBank Group announced a joint venture to commercialise brand-agnostic autonomous heavy equipment. SoftBank is providing $225 million in new funding to ASI. Mel Torrie, CEO of ASI, told The Robot Report that skilled equipment operators are hard to find. Coordinating mixed fleets across a large jobsite is a real bottleneck. That is a labour-market story, but it is also a distribution story.

Launch capacity and the satellites that carry the data

Above all of it sits communications capacity. Light Reading reported on 30 September that SpaceX's Starship launch and the deployment of the first batch of next-generation Starlink broadband satellites reignited concerns about a launch capacity shortage that could delay planned services. The Wall Street Journal reported that some companies have not been able to get flights on Falcon 9 after 2028, citing people familiar with the matter. SpaceX has not officially confirmed plans for Falcon 9. Musk posted on X in August that it makes sense to wind down Falcon once Starship is flying reliably.

Analysys Mason's Dallas Kasaboski told Light Reading that there are more than 230 constellation projects in development with 1.5 million satellites planned. Most are for orbital data centers. Stripping out data center craft leaves 133,000 satellites planned for launch. A record 5,000 satellites went into orbit in 2025, so at that rate it would take almost 27 years to launch all the planned satellites. He added that most will not be built, due to bankruptcies and mergers, but that more constellations continue to be announced.

For pharmacy operators, the near-term relevance is narrower than the satellite count suggests. Direct-to-device and broadband links underpin remote dispensing, cold-chain telemetry and rural clinic connectivity. If new LEO entrants are queued behind Starlink's own payloads, the services that depend on them slip too. Players needing launches include Amazon Leo, AST SpaceMobile, Elveo, Equatys, Open Cosmos, Telesat Lightspeed and Sateliot, according to Light Reading. AST SpaceMobile lost a satellite in April when Blue Origin's New Glenn put it into the wrong orbit. It later raised $1 billion in debt to secure launch capacity.

Clinical research is moving in the opposite direction, adding to the demand side of the same constrained inputs. Tohoku University researchers reported in ScienceDaily on 26 September that brain blood volume increases about 50 seconds before REM sleep begins, starting in the posterior cortex. Neuronal ATP falls once REM starts. The study used a UV-curable resin to make mouse skulls transparent and wide-field fluorescence imaging to track blood volume.

China's biotech and storage industries are climbing the same value chain from the other side. The South China Morning Post reported on 26 September that InnoCare Pharma entered a research collaboration and licensing agreement with Eli Lilly potentially worth up to $3.35 billion. It covers up to five targets, with no therapeutic areas disclosed. Separately, the SCMP reported on 23 September that Biwin Storage Technology will invest 4.5 billion yuan ($672 million) in the third phase of an advanced packaging and testing project in Dongguan. This is more than the 3.09 billion yuan spent on the first two phases combined. Monthly capacity is expected to more than triple to 10,000 wafers by the end of 2027.

What the shortage lists actually show

The UK lists have become the most visible yardstick. The Sun reported on 28 September that 216 NHS medicines are in short supply, with more ADHD and heart drugs facing issues. This followed a previous list of 243 that it published on 15 September. Birmingham Live reported on 29 September that the NHS confirmed a shortage of three common drugs in England. The Sun reported on 29 September that the crisis had hit six new skin medicines. The Pharmaceutical Journal reported on 29 September on the lives cut short by medicine shortages.

Some of the most stubborn cases are not new at all. Pharmacy Times reported on 28 September that five injectable drugs have been in shortage for more than a decade. That is the backdrop against which the semiconductor, battery and launch bottlenecks should be read: the pharmacy supply chain is not a separate system that will be fixed by a single procurement reform.

The sources disagree on the scale of the problem, and it is worth being explicit about that. Micron says the industry will remain supply constrained in both 2027 and 2028. ASI's Torrie frames autonomous fleets as a solution to labour bottlenecks rather than another dependency. The NHS lists count shortages of specific medicines; Micron counts wafers and bits.